Home › Melanoma › Nebraska › Omaha
Pag-aaral pangklinika para sa Melanoma sa Omaha, NE
Isang pag-aaral para sa Melanoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Omaha. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Nagre-recruitPhase 2
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
- Nebraska Medicine-Bellevue, Bellevue · 9 mi ang layo
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Nagre-recruitPhase 3
- Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Nagre-recruitPhase 1/2
- Nebraska Cancer Specialists, Omaha
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
Nagre-recruitPhase 1/2
- Nebraska Cancer Specialists, Omaha
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
Nagre-recruitPhase 3
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
Project: Every Child for Younger Patients With Cancer
Nagre-recruitObservasyonal na pag-aaral
- Children's Hospital and Medical Center of Omaha, Omaha
- University of Nebraska Medical Center, Omaha
Integrated Cancer Repository for Cancer Research
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Methodist Estabrook Cancer Center, Omaha
- Nebraska Methodist Health System, Omaha
- University of Nebraska Medical Center, Omaha
- at 1 pa
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Nagre-recruitPhase 3
- TIERING Percentiles, Omaha
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Omaha
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- University of Nebraska Medical Center, Omaha
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Nagre-recruit
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medicine, Omaha
- Nebraska Medicine - Bellevue, Bellevue · 9 mi ang layo
Pag-aaral para sa Melanoma sa ibang lungsod
- Houston, TX61 pag-aaral
- New York City, NY41 pag-aaral
- Nashville, TN34 pag-aaral
- Los Angeles, CA34 pag-aaral
- Pittsburgh, PA31 pag-aaral
- Boston, MA25 pag-aaral
- St. Louis, MO23 pag-aaral
- Durham, NC22 pag-aaral
- Philadelphia, PA22 pag-aaral
- Tampa, FL21 pag-aaral
- Columbus, OH21 pag-aaral
- Dallas, TX21 pag-aaral
Iba pang pag-aaral sa Omaha
- Kanser sa Prostate29 pag-aaral
- Non-Small Cell Lung Cancer25 pag-aaral
- Kanser sa Suso23 pag-aaral
- Kanser (lahat ng uri)19 pag-aaral
- Colorectal Cancer18 pag-aaral
- Multiple Myeloma17 pag-aaral
- Kanser sa Ovary15 pag-aaral
- Kanser sa Pancreas15 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg15 pag-aaral
- Metastatic Cancer14 pag-aaral
- Non-Hodgkin Lymphoma14 pag-aaral
- Kanser sa Baga13 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.